Anti-IL1 Therapy Does Not Affect the Response to SARS-COV-2 Vaccination and Infection in Patients with Systemic Autoinflammatory Diseases

Leonie Geck; Koray Tascilar; David Simon; Arnd Kleyer; Georg Schett; Juergen Rech

doi:10.20944/preprints202310.1087.v1

Preprint

Brief Report

Anti-IL1 Therapy Does Not Affect the Response to SARS-COV-2 Vaccination and Infection in Patients with Systemic Autoinflammatory Diseases

This version is not peer-reviewed.

Leonie Geck,

Koray Tascilar,David Simon,Arnd Kleyer,

Georg Schett,

Juergen Rech^*

Leonie Geck,

Koray Tascilar,David Simon,Arnd Kleyer,

Georg Schett,

Juergen Rech^*

This version is not peer-reviewed.

Altmetrics

Downloads

145

Views

Comments

Submitted:

16 October 2023

Posted:

17 October 2023

You are already at the latest version

A peer-reviewed article of this preprint also exists.

Abstract

Keywords:

Subject:

Medicine and Pharmacology - Clinical Medicine

This preprints belongs to the Collection

Preprints on COVID-19 and SARS-CoV-2

Copyright: This open access article is published under a Creative Commons CC BY 4.0 license, which permit the free download, distribution, and reuse, provided that the author and preprint are cited in any reuse.

Alerts

MDPI Initiatives

Important Links

Choose an area of interest and we will send you notifications of new preprints at your preferred frequency.

Disclaimer

Anti-IL1 Therapy Does Not Affect the Response to SARS-COV-2 Vaccination and Infection in Patients with Systemic Autoinflammatory Diseases

Abstract

Keywords:

Subject:

MDPI Initiatives

Important Links

Subscribe